Stay updated on Pembrolizumab for Biliary Tract Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Biliary Tract Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Biliary Tract Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the funding-status notice and the previous Revision: v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-11T01:17:14.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Added a government funding lapse notice banner. Updated the site revision from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T00:24:18.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The changes add a glossary display toggle and update page metadata by introducing 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0', while removing the older labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-27T23:46:07.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.3 to v3.3.4; no visible content or layout changes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-13T17:42:45.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.3.3. The HHS Vulnerability Disclosure link and the previous Revision: v3.3.2 were removed.
    Difference
    0.1%
    Check dated 2025-12-23T08:44:06.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    Revision: v3.3.2 is now displayed, replacing v3.3.1; no observable changes to study content, endpoints, contacts, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:47:39.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Biliary Tract Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Biliary Tract Cancer Clinical Trial page.